Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M341Revenue (TTM) $M9.5Net Margin (%)-1,319.1Altman Z-Score-2.2
Enterprise Value $M187EPS (TTM) $-1.1Operating Margin %-1,363.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.1Pre-tax Margin (%)-1,319.1Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio5.6Cash flow > EarningsY
Price/Sales32.05-y EBITDA Growth Rate %7.5Current Ratio5.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-38.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-52.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M128ROIC % (ttm)-237.7Gross Margin Increase y-yN

Gurus Latest Trades with CLDX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

CLDX is held by these investors:

CLDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KELER TIBORExecutive VP & CSO 2016-09-02Buy3,000$3.32-25.9view
CATLIN AVERY WSr. VP & CFO 2015-11-23Sell25,000$18-86.33view
ELLBERGER LARRYDirector 2015-08-25Buy5,000$14-82.43view
ELLBERGER LARRYDirector 2015-08-20Buy5,000$15-83.6view
ELLBERGER LARRYDirector 2015-08-18Buy5,000$15.95-84.58view
ELLBERGER LARRYDirector 2015-08-13Buy5,000$16.59-85.17view
Marucci Anthony SPresident and CEO 2015-08-13Buy5,800$16.81-85.37view
CATLIN AVERY WSr. VP & CFO 2015-06-15Sell25,000$24.59-90view
van den Broek RichardDirector 2014-12-17Sell0$0-90view
LIPTON KAREN SHOOSDirector 2013-12-06Sell17,728$24.5-89.96view

Press Releases about CLDX :

Quarterly/Annual Reports about CLDX:

News about CLDX:

Articles On GuruFocus.com
Celldex Announces Departure of Chief Medical Officer Sep 12 2017 
Celldex Announces Completion of Enrollment in Phase 2b Study of Glembatumumab Vedotin in Triple Nega Aug 23 2017 
Celldex to Report Second Quarter 2017 Financial Results and Host Corporate Update Call Aug 02 2017 
Celldex Therapeutics Announces Additions to the Board of Directors and Senior Management Team Jun 16 2017 
Celldex Therapeutics to Participate in the Jefferies 2017 Global Healthcare Conference Jun 06 2017 
Celldex Therapeutics Presents Phase 1 Study of Varlilumab and Opdivo® at 2017 ASCO Annual Meeti Jun 05 2017 
Celldex Presents Promising Overall Survival Data from Phase 2 Study of Single-agent Glembatumumab Ve Jun 05 2017 
George O. Elston Named Chief Executive Officer of 2X Oncology May 30 2017 
Celldex Reports First Quarter 2017 Results May 09 2017 
Celldex Therapeutics Announces Appointment to Board of Directors Mar 01 2017 

More From Other Websites
3 Small-Cap Biotech Stocks to Buy This Fall Sep 21 2017
Celldex Announces Departure of Chief Medical Officer Sep 12 2017
ETFs with exposure to Celldex Therapeutics, Inc. : September 12, 2017 Sep 11 2017
Today's Research Reports on Trending Tickers: AVEO Pharmaceuticals, Inc. and Celldex Therapeutics,... Sep 08 2017
ETFs with exposure to Celldex Therapeutics, Inc. : August 31, 2017 Aug 31 2017
Celldex Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CLDX-US : August... Aug 29 2017
3 Top Healthcare Stocks to Buy Now Aug 24 2017
Celldex Ends Phase II Enrollment for Breast Cancer Candidate Aug 24 2017
Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Aug 24 2017
Celldex Announces Completion of Enrollment in Phase 2b Study of Glembatumumab Vedotin in Triple... Aug 23 2017
3 Top Biotech Stocks Under $10 Aug 19 2017
Celldex Therapeutics, Inc. – Value Analysis (NASDAQ:CLDX) : August 17, 2017 Aug 16 2017
3 Beaten-Up Biotech Stocks: Are They Bargains? Aug 14 2017
Edited Transcript of CLDX earnings conference call or presentation 8-Aug-17 8:30pm GMT Aug 14 2017
Celldex (CLDX) Q2 Loss Narrows, Revenues Beat, Shares Up Aug 09 2017
Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum Aug 09 2017
Celldex reports 2Q loss Aug 08 2017
Celldex Reports Second Quarter 2017 Results Aug 08 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat